Soluble guanylyl cyclase expression is reduced in LPS-induced lung injury

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 292, Issue 4, 2007, Pages

  Glynos, Constantinos ^a   Kotanidou, Anastasia ^a   Orfanos, Stylianos E ^a,b   Zhou, Zongmin ^a   Simoes, Davina C M ^a   Magkou, Christina ^a   Roussos, Charis ^a   Papapetropoulos, Andreas ^a,c  

^a UNIVERSITY OF ATHENS   (Greece)

^b NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

^c UNIVERSITY OF PATRAS   (Greece)

Author keywords

Acute lung injury; Endotoxin; Guanosine 3 ,5 cyclic monophosphate

Indexed keywords

1H[1,2,4]OXODIAZOLO[4,3 A]QUINOXALIN 1 ONE; ENDOTOXIN; GUANYLATE CYCLASE; LIPOPOLYSACCHARIDE; QUINOXALINE; SOLUBLE GUANYLATE CYCLASE ALPHA1; SOLUBLE GUANYLATE CYCLASE BETA1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ACUTE LUNG INJURY; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

AEROSOLS; ANIMALS; BLOTTING, WESTERN; BRONCHI; BRONCHOALVEOLAR LAVAGE FLUID; CYCLIC GMP; ENZYME INHIBITORS; EPITHELIAL CELLS; GUANYLATE CYCLASE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INHALATION; LIPOPOLYSACCHARIDES; LUNG; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MUSCLE, SMOOTH; OXADIAZOLES; PROTEIN SUBUNITS; QUINOXALINES; RESPIRATORY DISTRESS SYNDROME, ADULT; RNA, MESSENGER; SOLUBILITY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 34147152676     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00341.2006     Document Type: Article

References (40)

1. Ahluwalia A, Foster P, Scotland RS, McLean PG, Mathur A, Perretti M, Moncada S, Hobbs AJ. Antiinflammatory activity of soluble guanylate cyclase: cGMP-dependent down-regulation of P-selectin expression and leukocyte recruitment. Proc Natl Acad Sci USA 101: 1386-1391, 2004.
2. Astiz M, Rackow E. Septic shock. Lancet 351: 1501-1505, 1998.
3. Balashova N, Chang FJ, Lamothe M, Sun Q, Beuve A. Characterization of a novel type of endogenous activator of soluble guanylyl cyclase. J Biol Chem 280: 2186-2196, 2005.
4. Buechler WA, Nakane M, Murad F. Expression of soluble guanylate cyclase activity requires both enzyme subunits. Biochem Biophys Res Commun 174: 351-357, 1991.
5. Davis KL, Martin E, Turko IV, Murad F. Novel effects of nitric oxide. Annu Rev Pharmacol Toxicol 41: 203-236, 2001.
6. Doerschuk C. Mechanisms of leukocyte sequestration in inflamed lungs. Microcirculation 8: 71-88, 2001.
7. Filippov G, Bloch DB, Bloch KD. Nitric oxide decreases stability of mRNAs encoding soluble guanylate cyclase subunits in rat pulmonary artery smooth muscle cells. J Clin Invest 100: 942-948, 1997.
8. Friebe A, Koesling D. Regulation of nitric oxide-sensitive guanylyl cyclase. Circ Res 93: 96-105, 2003.
9. Hanafy KA, Martin E, Murad F. CCTε, a novel soluble guanylyl cyclase-interacting protein. J Biol Chem 279: 46946-46953, 2004.
10. Kloss S, Furneaux H, Mulsch A. Post-transcriptional regulation of soluble guanylyl cyclase expression in rat aorta. J Biol Chem 278: 2377-2383, 2003.
11. Kloss S, Srivastava R, Mulsch A. Down-regulation of soluble guanylyl cyclase expression by cyclic AMP is mediated by mRNA-stabilizing protein HuR. Mol Pharmacol 65: 1440-1451, 2004.
12. Krumenacker JS, Kots A, Murad F. Effects of the JNK inhibitor anthra[1,9-cd]pyrazol-6(2H)-one (SP-600125) on soluble guanylyl cyclase α1 gene regulation and cGMP synthesis. Am J Physiol Cell Physiol 289: C778-C784, 2005.
13. Liu P, Xu B, Hock C. Inhibition of nitric oxide synthesis by L-NAME exacerbates acute lung injury induced by hepatic ischemia-reperfusion. Shock 16: 211-217, 2001.
14. Lofton CE, Newman WH, Currie MG. Atrial natriuretic peptide regulation of endothelial permeability is mediated by cGMP. Biochem Biophys Res Commun 172: 793-799, 1990.
15. Lucas KA, Pitari GM, Kazerounian S, Ruiz-Stewart I, Park J, Schulz S, Chepenik KP, Waldman SA. Guanylyl cyclases and signaling by cyclic GMP. Pharmacol Rev 52: 375-414, 2000.
16. Mehta S. The effects of nitric oxide in acute lung injury. Vasa 43: 390-403, 2005.
17. Mergia E, Friebe A, Dangel O, Russwurm M, Koesling D. Spare guanylyl cyclase NO receptors ensure high NO sensitivity in the vascular system. J Clin Invest 116: 1731-1737, 2006.
18. Mergia E, Russwurm M, Zoidl G, Koesling D. Major occurrence of the new α2β1 isoform of NO-sensitive guanylyl cyclase in brain. Cell Signal 15: 189-195, 2003.
19. Meurer S, Pioch S, Wagner K, Muller-Esterl W, Gross S. AGAP1, a novel binding partner of nitric oxide-sensitive guanylyl cyclase. J Biol Chem 279: 49346-49354, 2004.
20. Moldobaeva A, Welsh-Servinsky LE, Shimoda LA, Stephens RS, Verin AD, Tuder RM, Pearse DB. Role of protein kinase G in barrier-protective effects of cGMP in human pulmonary artery endothelial cells. Am J Physiol Lung Cell Mol Physiol 290: L919 -L930, 2006.
21. Moncada S, Palmer RM, Higgs EA. Nitric oxide: physiology, pathophysiology, pharmacology. Pharmacol Rev 43: 109-142, 1991.
22. Orfanos S, Mavrommati I, Korovesi I, Roussos C. Pulmonary endothelium in acute lung injury: from basic science to the critically ill. Intensive Care Med 30: 1702-1714, 2004.
23. Papapetropoulos A, Abou-Mohamed G, Marczin N, Murad F, Caldwell R, Catravas J. Downregulation of nitrovasodilator-induced cyclic GMP accumulation in cells exposed to endotoxin or interleukin-1 beta. Br J Pharmacol 118: 1359-1366, 1996.
24. Papapetropoulos A, Go C, Murad F, Catravas J. Mechanisms of tolerance to sodium nitroprusside in rat cultured aortic smooth muscle cells. Br J Pharmacol 117: 147-155, 1996.
25. Papapetropoulos A, Simoes DCM, Xanthou G, Roussos C, Gratziou C. Soluble guanylyl cyclase expression is reduced in allergic asthma. Am J Physiol Lung Cell Mol Physiol 290: L179-L184, 2006.
26. Papapetropoulos A, Zhou Z, Gerassimou C, Yetik G, Venema RC, Roussos C, Sessa WC, Catravas JD. Interaction between the 90-kDa heat shock protein and soluble guanylyl cyclase: physiological significance and mapping of the domains mediating binding. Mol Pharmacol 68: 1133-1141, 2005.
27. Pearse DB, Wagner EM, Permutt S. Effect of ventilation on vascular permeability and cyclic nucleotide concentrations in ischemic sheep lungs. J Appl Physiol 86: 123-132, 1999.
28. Pinsky D, Naka Y, Chowdhury N, Liao H, Oz M, Michler R, Kubaszewski E, Malinski T, Stern D. The nitric oxide/cyclic GMP pathway in organ transplantation: critical role in successful lung preservation. Proc Natl Acad Sci USA 91: 12086-12090, 1994.
29. Pyriochou A, Papapetropoulos A. Soluble guanylyl cyclase: more secrets revealed. Cell Signal 17: 407-413, 2005.
30. Rose F, Guthmann B, Tenenbaum T, Fink L, Ghofrani A, Weissmann N, Konig P, Ermert L, Dahlem G, Haenze J, Kummer W, Seeger W, Grimminger F. Apical, but not basolateral, endotoxin preincubation protects alveolar epithelial cells against hydrogen peroxide-induced loss of barrier function: the role of nitric oxide synthesis. J Immunol 169: 1474 -1481, 2002.
31. Rubenfeld G. Epidemiology of acute lung injury. Crit Care Med 4 Suppl: S276-S284, 2003.
32. Russwurm M, Wittau N, Koesling D. Guanylyl cyclase/PSD-95 interaction: targeting of the nitric oxide-sensitive α2β1 guanylyl cyclase to synaptic membranes. J Biol Chem 276: 44647-44652, 2001.
33. Scott WS, Nakayama DK. Escherichia coli lipopolysaccharide down-regulates soluble guanylate cyclase in pulmonary artery smooth muscle. J Surg Res 80: 309-314, 1998.
34. Takata M, Filippov G, Liu H, Ichinose F, Janssens S, Bloch DB, Bloch KD. Cytokines decrease sGC in pulmonary artery smooth muscle cells via NO-dependent and NO-independent mechanisms. Am J Physiol Lung Cell Mol Physiol 280: L272-L278, 2001.
35. Tate R, Repine J. Neutrophils and the adult respiratory distress syndrome. Am Rev Respir Dis 128: 552-559, 1983.
36. Terada LS, Mahr NN, Jacobson ED. Nitric oxide decreases lung injury after intestinal ischemia. J Appl Physiol 81: 2456-2460, 1996.
37. Ware LB, Matthay MA. The acute respiratory distress syndrome. N Engl J Med 342: 1334-1349, 2000.
38. Wedgwood S, Steinhorn RH, Bunderson M, Wilham J, Lakshminrusimha S, Brennan LA, Black SM. Increased hydrogen peroxide downregulates soluble guanylate cyclase in the lungs of lambs with persistent pulmonary hypertension of the newborn. Am J Physiol Lung Cell Mol Physiol 289: L660-L666, 2005.
39. Yamashita T, Kawashima S, Ohashi Y, Ozaki M, Ueyama T, Ishida T, Inoue N, Hirata Ki Akita H, Yokoyama M. Resistance to endotoxin sock in transgenic mice overexpressing endothelial nitric oxide synthase. Circulation 101: 931-937, 2000.
40. Zacharowski K, Berkels R, Olbrich A, Chatterjee P, Cuzzocrea S, Foster S, Thiemermann C. The selective guanylate cyclase inhibitor ODQ reduces multiple organ injury in rodent models of Gram-positive and Gram-negative shock. Crit Care Med 29: 1599-1608, 2001.